| (GBp) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 3.35B | 7.10% |
| Operating expense | — | — |
| Net income | 402.00M | 11.98% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HIK.L returned -11.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +5.4% |
| 1 year | -11.0% |
| 5 years | -35.5% |
| 10 years | -23.5% |
| All-time high | GBX 2,646.00 (Jul 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what £1,000 in HIK.L would be worth today ›Yes. Hikma Pharmaceuticals PLC paid 2 dividends over the past 12 months. The most recent was GBX 27.87 per share on Aug 13, 2026. The dividend yield is 3.88%.
Hikma Pharmaceuticals PLC is part of the Healthcare sector.
Hikma Pharmaceuticals PLC has a market cap of 3.38B GBp, based on the latest quote.
